Cargando…

Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K(Ca)3.1) channels in vivo

Expression of the Ca(2+) activated potassium channel 3.1 (K(Ca)3.1) channel (also known as the Gàrdos channel) is dysregulated in many tumor entities and has predictive power with respect to patient survival. Therefore, a positron emission tomography (PET) tracer targeting this ion channel could ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brömmel, Kathrin, Konken, Christian Paul, Börgel, Frederik, Obeng-Darko, Henry, Schelhaas, Sonja, Bulk, Etmar, Budde, Thomas, Schwab, Albrecht, Schäfers, Michael, Wünsch, Bernhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041111/ https://www.ncbi.nlm.nih.gov/pubmed/35480282 http://dx.doi.org/10.1039/d1ra03850h

Ejemplares similares

Co‐staining of K(Ca)3.1 Channels in NSCLC Cells with a Small‐Molecule Fluorescent Probe and Antibody‐Based Indirect Immunofluorescence
por: Brömmel, Kathrin, et al.
Publicado: (2020)

Synthesis of Small‐Molecule Fluorescent Probes for the In Vitro Imaging of Calcium‐Activated Potassium Channel K(Ca)3.1
por: Brömmel, Kathrin, et al.
Publicado: (2020)

Functional expression of mitochondrial K(Ca)3.1 channels in non-small cell lung cancer cells
por: Bulk, Etmar, et al.
Publicado: (2022)

K(Ca)3.1 channel inhibition leads to an ICAM-1 dependent increase of cell-cell adhesion between A549 lung cancer and HMEC-1 endothelial cells
por: Bulk, Etmar, et al.
Publicado: (2017)

Imaging of K(Ca)3.1 Channels in Tumor Cells with PET and Small‐Molecule Fluorescent Probes
por: Thale, Insa, et al.
Publicado: (2022)

The Role of TRP Channels in the Metastatic Cascade
por: Fels, Benedikt, et al.
Publicado: (2018)

Histidine phosphorylation relieves copper inhibition in the mammalian potassium channel KCa3.1
por: Srivastava, Shekhar, et al.
Publicado: (2016)

The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury
por: Sevelsted Møller, Linda, et al.
Publicado: (2016)

Antidepressant drug paroxetine blocks the open pore of Kv3.1 potassium channel
por: Lee, Hyang Mi, et al.
Publicado: (2018)

A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels
por: Cui, Meng, et al.
Publicado: (2021)

Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma
por: Catacuzzeno, Luigi, et al.
Publicado: (2012)

Control of KirBac3.1 Potassium Channel Gating at the Interface between Cytoplasmic Domains
por: Zubcevic, Lejla, et al.
Publicado: (2014)

Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Contribution of the KCa3.1 channel–calmodulin interactions to the regulation of the KCa3.1 gating process
por: Morales, Patricia, et al.
Publicado: (2013)

The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke
por: Yi, Mengni, et al.
Publicado: (2017)

Correction: Crystal structure of the C-terminal four-helix bundle of the potassium channel KCa3.1
por: Ji, Tianyang, et al.
Publicado: (2018)

Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions
por: Chiang, Eugene Y., et al.
Publicado: (2017)

K(Ca)3.1 Channels and Glioblastoma: In Vitro Studies
por: Klumpp, Lukas, et al.
Publicado: (2018)

Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels
por: Lee, Hyang Mi, et al.
Publicado: (2023)

K(Ca) channel blockers increase effectiveness of the EGF receptor TK inhibitor erlotinib in non-small cell lung cancer cells (A549)
por: Glaser, Felix, et al.
Publicado: (2021)

Characterization of the PCMBS-dependent modification of KCa3.1 channel gating
por: Bailey, Mark A., et al.
Publicado: (2010)

KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo
por: D'Alessandro, G, et al.
Publicado: (2013)

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma
por: Brown, Brandon M., et al.
Publicado: (2018)

The intermediate‐conductance calcium‐activated potassium channel KCa3.1 contributes to alkalinization‐induced vascular calcification in vitro
por: Bai, Yaling, et al.
Publicado: (2021)

Contribution of the Potassium Channels K(V)1.3 and K(Ca)3.1 to Smooth Muscle Cell Proliferation in Growing Collateral Arteries
por: Lasch, Manuel, et al.
Publicado: (2020)

Ca(2+)-activated KCa3.1 potassium channels contribute to the slow afterhyperpolarization in L5 neocortical pyramidal neurons
por: Roshchin, M. V., et al.
Publicado: (2020)

KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment
por: D'Alessandro, Giuseppina, et al.
Publicado: (2016)

The expression of Cav3.1 on T-type calcium channels of rats with subarachnoid hemorrhage
por: Zhang, Xinwen, et al.
Publicado: (2020)

K(Ca)3.1 Channels Confer Radioresistance to Breast Cancer Cells
por: Mohr, Corinna J., et al.
Publicado: (2019)

pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology
por: Pethő, Zoltán, et al.
Publicado: (2020)

Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (K(Ca)3.1) in endothelial cells to promote angiogenesis
por: Pham, Dylan L., et al.
Publicado: (2022)

Microglial KCa3.1 Channels as a Potential Therapeutic Target for Alzheimer's Disease
por: Maezawa, Izumi, et al.
Publicado: (2012)

Functional K(Ca)3.1 K(+) channels are required for human fibrocyte migration
por: Cruse, Glenn, et al.
Publicado: (2011)

KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis
por: Anumanthan, Govindaraj, et al.
Publicado: (2018)

Involvement of KCa3.1 channel activity in immediate perioperative cognitive and neuroinflammatory outcomes
por: Saxena, Sarah, et al.
Publicado: (2023)

First Evidence of Kv3.1b Potassium Channel Subtype Expression during Neuronal Serotonergic 1C11 Cell Line Development
por: Tabka, Hager, et al.
Publicado: (2020)

The Long Non-Coding RNA-14327.1 Promotes Migration and Invasion Potential of Endometrial Carcinoma Cells by Stabilizing the Potassium Channel Kca3.1
por: Zhang, Yingli, et al.
Publicado: (2019)

Expression and Localization of Kv1.1 and Kv3.1b Potassium Channels in the Cochlear Nucleus and Inferior Colliculus after Long-Term Auditory Deafferentation
por: Poveda, Clara M., et al.
Publicado: (2020)

Differential DNA methylation of potassium channel KCa3.1 and immune signalling pathways is associated with infant immune responses following BCG vaccination
por: Hasso-Agopsowicz, Mateusz, et al.
Publicado: (2018)

Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo
por: Bachmann, Magdalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7cb23bemfi0kgiara49bh3fq1